Home LiteratureArticle Details
PMID: 1039311 Published · ppublish English Comparative Study Journal Article

Inactivation of cefazolin, cephaloridine, and cephalothin by methicillin-sensitive and methicillin-resistant strains of Staphylococcus aureus.

The Journal of infectious diseases ·Vol. 131 ·No. 3 ·1975-03-00 ·Pages 291-4

Regamey C, Libke RD, Engelking ER, Clarke JT, Kirby MM

Abstract

Cefazolin was more susceptible than cephaloridine and cephalothin to in vitro inactivation by coagulase-positive, penicillinase-producing strains of Staphylococcus aureus. Inactivation (which was greater with methicillin-resistant than with methicillin-sensitive strains) was demonstrated by assay of the antibiotics in broth cultures with simultaneous colony counts and by exposure of the antibiotics to penicillinase powders extracted from S. aureus. Cefazolin was destroyed to a greater extent than was cephaloridine, whereas cephalothin underwent little, if any, destruction. The clinical implications of this degradation, thought by some to be of importance for cephaloridine, might also apply to cefazolin.

MeSH Terms
Cefazolin/metabolism Cephaloridine/metabolism Cephalosporins/metabolism Cephalothin/metabolism Culture Media Methicillin/pharmacology Microbial Sensitivity Tests Penicillin Resistance Staphylococcus/drug effects,metabolism
Chemicals
Cephalosporins Culture Media Cefazolin Cephaloridine Methicillin Cephalothin
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Regamey C
Libke R D
Engelking E R
Clarke J T
Kirby M M
Article Info
Journal
The Journal of infectious diseases
Abbr.
J Infect Dis
ISSN
0022-1899
Published
1975-03-00
Pages
291-4
Language
English
Region
United States
NLM ID
0413675
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]